ZA200802247B - Chimeric antibodies with new world primate regions - Google Patents
Chimeric antibodies with new world primate regionsInfo
- Publication number
- ZA200802247B ZA200802247B ZA200802247A ZA200802247A ZA200802247B ZA 200802247 B ZA200802247 B ZA 200802247B ZA 200802247 A ZA200802247 A ZA 200802247A ZA 200802247 A ZA200802247 A ZA 200802247A ZA 200802247 B ZA200802247 B ZA 200802247B
- Authority
- ZA
- South Africa
- Prior art keywords
- regions
- chimeric antibodies
- new world
- world primate
- primate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005904406A AU2005904406A0 (en) | 2005-08-15 | New World Antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200802247B true ZA200802247B (en) | 2009-08-26 |
Family
ID=37757238
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200802247A ZA200802247B (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions |
| ZA200802246A ZA200802246B (en) | 2005-08-15 | 2006-08-15 | Engineered antibodies with new world primate framework regions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200802246A ZA200802246B (en) | 2005-08-15 | 2006-08-15 | Engineered antibodies with new world primate framework regions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1945669A4 (pt) |
| JP (1) | JP2009504686A (pt) |
| KR (1) | KR20080068005A (pt) |
| CN (2) | CN101287762A (pt) |
| AU (1) | AU2006281981A1 (pt) |
| BR (2) | BRPI0614867A2 (pt) |
| CA (1) | CA2619245A1 (pt) |
| MX (1) | MX2008002161A (pt) |
| NO (1) | NO20080800L (pt) |
| NZ (1) | NZ565904A (pt) |
| RU (1) | RU2008110058A (pt) |
| WO (1) | WO2007019621A1 (pt) |
| ZA (2) | ZA200802247B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005287406B2 (en) | 2004-07-26 | 2011-08-18 | Biogen Ma Inc. | Anti-CD154 antibodies |
| NZ569988A (en) | 2006-02-01 | 2011-09-30 | Cephalon Australia Pty Ltd | Domain antibody construct which binds to human TNF-alpha and contains a modified hinge region sequence and a truncated CH1 domain |
| BRPI0809042B1 (pt) * | 2007-03-22 | 2021-08-31 | Biogen Ma Inc. | Proteína de ligação a cd154 isolada, seu uso, e composição |
| US20110319597A1 (en) * | 2008-08-14 | 2011-12-29 | Caphalon Australia Pty. Ltd. | Variant domain antibodies |
| RU2535033C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
| RU2577299C2 (ru) * | 2011-07-04 | 2016-03-10 | Олег Ильич Эпштейн | Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний |
| RU2502521C2 (ru) * | 2010-08-06 | 2013-12-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций |
| RU2516931C2 (ru) * | 2010-08-06 | 2014-05-20 | Олег Ильич Эпштейн | Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
| RU2505312C2 (ru) * | 2010-08-06 | 2014-01-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения гриппа различных типов |
| RU2519862C2 (ru) * | 2010-08-06 | 2014-06-20 | Олег Ильич Эпштейн | Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний |
| RU2521392C2 (ru) * | 2010-08-06 | 2014-06-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний |
| RU2517085C2 (ru) * | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
| RU2535034C2 (ru) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида |
| RU2579262C1 (ru) * | 2014-10-02 | 2016-04-10 | Мапикс Эс.Эй.Ар.Эл. | Лекарственное средство для лечения инфекционных заболеваний |
| CL2015002152A1 (es) * | 2015-07-31 | 2016-06-03 | Pontificia Universidad Católica De Chile | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh |
| CN120366228B (zh) * | 2025-04-24 | 2026-06-26 | 梅州市人民医院(梅州市医学科学院) | 一种分泌钙调宁蛋白2单克隆抗体的杂交瘤细胞株2f8、单克隆抗体及制备和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243706A (en) * | 1991-07-25 | 1994-08-26 | Idec Pharma Corp | Recombinant monkey antibodies, pharmaceutical compositions |
| US6569431B2 (en) * | 2000-10-17 | 2003-05-27 | The Regents Of The University Of California | Recombinant antibody fragments as autoantibody antagonists |
| US7235643B2 (en) * | 2000-11-07 | 2007-06-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with high affinity |
| CN1678634A (zh) * | 2002-06-28 | 2005-10-05 | 多曼蒂斯有限公司 | 免疫球蛋白单个变体抗原结合区及其特异性构建体 |
| JP2007534305A (ja) * | 2003-11-07 | 2007-11-29 | アムジェン インコーポレイテッド | サル免疫グロブリン配列 |
-
2006
- 2006-08-15 CN CNA2006800381577A patent/CN101287762A/zh active Pending
- 2006-08-15 KR KR1020087006270A patent/KR20080068005A/ko not_active Ceased
- 2006-08-15 BR BRPI0614867-0A patent/BRPI0614867A2/pt not_active IP Right Cessation
- 2006-08-15 WO PCT/AU2006/001166 patent/WO2007019621A1/en not_active Ceased
- 2006-08-15 NZ NZ565904A patent/NZ565904A/en not_active IP Right Cessation
- 2006-08-15 ZA ZA200802247A patent/ZA200802247B/xx unknown
- 2006-08-15 RU RU2008110058/13A patent/RU2008110058A/ru not_active Application Discontinuation
- 2006-08-15 MX MX2008002161A patent/MX2008002161A/es not_active Application Discontinuation
- 2006-08-15 CA CA002619245A patent/CA2619245A1/en not_active Abandoned
- 2006-08-15 CN CNA2006800382565A patent/CN101287763A/zh active Pending
- 2006-08-15 AU AU2006281981A patent/AU2006281981A1/en not_active Abandoned
- 2006-08-15 JP JP2008526323A patent/JP2009504686A/ja active Pending
- 2006-08-15 EP EP06774813A patent/EP1945669A4/en not_active Withdrawn
- 2006-08-15 BR BRPI0614430-6A patent/BRPI0614430A2/pt not_active IP Right Cessation
- 2006-08-15 ZA ZA200802246A patent/ZA200802246B/xx unknown
-
2008
- 2008-02-14 NO NO20080800A patent/NO20080800L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0614430A2 (pt) | 2011-03-29 |
| NO20080800L (no) | 2008-05-09 |
| ZA200802246B (en) | 2009-09-30 |
| NZ565904A (en) | 2012-02-24 |
| MX2008002161A (es) | 2008-04-22 |
| CA2619245A1 (en) | 2007-02-22 |
| JP2009504686A (ja) | 2009-02-05 |
| KR20080068005A (ko) | 2008-07-22 |
| RU2008110058A (ru) | 2009-09-27 |
| CN101287763A (zh) | 2008-10-15 |
| WO2007019621A1 (en) | 2007-02-22 |
| BRPI0614867A2 (pt) | 2012-01-31 |
| AU2006281981A1 (en) | 2007-02-22 |
| CN101287762A (zh) | 2008-10-15 |
| EP1945669A1 (en) | 2008-07-23 |
| EP1945669A4 (en) | 2009-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1945668A4 (en) | SYNTHETIC ANTIBODIES WITH FRAMEWORK REGIONS OF NEUWELTPRIMATEN | |
| PT1874927E (pt) | Celulases melhoradas | |
| IL187106A (en) | Sclerostin binds antibody | |
| IL190472A0 (en) | Anti-glypican-3 antibody | |
| ZA200805850B (en) | Anti-ILT7 antibody | |
| IL186739A0 (en) | Antibodies to myostatin | |
| IL185366A0 (en) | Antibody | |
| PT2011869E (pt) | Novo anticorpo anti-cd98 | |
| EP1945669A4 (en) | CHIMERIC ANTIBODIES WITH NEUWELTPRIMATENREGIONEN | |
| PL1863747T3 (pl) | Sposób hydroformylowania o ulepszonej izo-selektywności | |
| GB0517487D0 (en) | Antibodies | |
| EP1969009A4 (en) | CHIMERIC ANTIBODIES AT PRIMATE PARTIAL BINDING REGIONS OF THE NEW WORLD | |
| EP1896047A4 (en) | ANTI-GFRALPHA3 ANTIBODIES | |
| IL189265A0 (en) | Ferrocene-diphosphine ligands | |
| GB0505489D0 (en) | Antibodies | |
| GB0505054D0 (en) | Antibodies | |
| GB0512278D0 (en) | Antibodies | |
| GB0519883D0 (en) | Antibodies | |
| GB0509392D0 (en) | Improvements to the controllable petrol can | |
| GB0616587D0 (en) | Intelligent buggy | |
| GB0521710D0 (en) | Fork extension | |
| GB0607376D0 (en) | Antibodies | |
| GB0606276D0 (en) | Antibodies | |
| GB0503580D0 (en) | Travel phone | |
| GB0500400D0 (en) | Antibody |